Literature DB >> 26310697

The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor development.

Cassandra J Adams1, Jennifer S Yu2, Jian-Hua Mao3, Kuang-Yu Jen4, Sylvain V Costes3, Mark Wade5, Jocelyn Shoemake2, Olulanu H Aina6, Reyno Del Rosario1, Phuong Thuy Menchavez1, Robert D Cardiff6, Geoffrey M Wahl7, Allan Balmain1.   

Abstract

The tumor suppressor TP53 can initiate a plethora of anti-proliferative effects to maintain genomic integrity under conditions of genotoxic stress. The N-terminal proline-rich domain (PRD) of TP53 is important in the regulation of TP53 activity and stability. A common polymorphism at codon 72 in this region has been associated with altered cancer risk in humans. The Trp53ΔP mouse, which carries a germline homozygous deletion of a region of the PRD, does not develop spontaneous tumors in a mixed 129/Sv and C57BL/6 genetic background, but is highly susceptible to a broad range of tumor types following total body exposure to 4 Gy gamma (γ) radiation. This contrasts with the tumor spectrum in Trp53 null (-/-) mice, which mainly develop thymic lymphomas and osteosarcomas. Analysis of genomic instability in tissues and cells from Trp53ΔP mice demonstrated elevated basal levels of aneuploidy, but this is not sufficient to drive spontaneous tumorigenesis, which requires an additional DNA damage stimulus. Levels of genomic instability did not increase significantly in Trp53ΔP mice following irradiation exposure, suggesting that other radiation effects including tissue inflammation, altered metabolism or autophagy, may play an important role. The Trp53ΔP mouse is a novel model to dissect the mechanisms of tumor development induced by radiation exposure.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Trp53; cancer radiation; genomic instability

Mesh:

Substances:

Year:  2015        PMID: 26310697      PMCID: PMC4891300          DOI: 10.1002/mc.22377

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  35 in total

1.  The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.

Authors:  Sara J Edwards; Lynne Hananeia; Michael R Eccles; You Fang Zhang; Antony W Braithwaite
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

2.  Debate surges over the origins of genomic defects in cancer.

Authors:  Jean Marx
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

3.  Identification of Hipk2 as an essential regulator of white fat development.

Authors:  Jonas Sjölund; Facundo G Pelorosso; David A Quigley; Reyno DelRosario; Allan Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-30       Impact factor: 11.205

4.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.

Authors:  Jian-Hua Mao; Jesus Perez-Losada; Di Wu; Reyno Delrosario; Ryosuke Tsunematsu; Keiichi I Nakayama; Ken Brown; Sheila Bryson; Allan Balmain
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

5.  Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains.

Authors:  H Szymanska; M Sitarz; E Krysiak; J Piskorowska; A Czarnomska; H Skurzak; A A Hart; D de Jong; P Demant
Journal:  Int J Cancer       Date:  1999-11-26       Impact factor: 7.396

6.  Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD).

Authors:  H G Campbell; R Mehta; A A Neumann; C Rubio; M Baird; T L Slatter; A W Braithwaite
Journal:  Oncogene       Date:  2012-04-09       Impact factor: 9.867

7.  A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

Authors:  Franck Toledo; Kurt A Krummel; Crystal J Lee; Chung-Wen Liu; Luo-Wei Rodewald; Mengjia Tang; Geoffrey M Wahl
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

8.  Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers.

Authors:  Robert D Cardiff; Neil E Hubbard; Jesse A Engelberg; Robert J Munn; Claramae H Miller; Judith E Walls; Jane Q Chen; Héctor A Velásquez-García; Jose J Galvez; Katie J Bell; Laurel A Beckett; Yue-Ju Li; Alexander D Borowsky
Journal:  Lab Invest       Date:  2013-02-11       Impact factor: 5.662

9.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

10.  Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma.

Authors:  J-H Mao; D Wu; I-J Kim; H C Kang; G Wei; J Climent; A Kumar; F G Pelorosso; R DelRosario; E J Huang; A Balmain
Journal:  Oncogene       Date:  2011-07-25       Impact factor: 9.867

View more
  4 in total

1.  The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Authors:  Katherine Baran; Mao Yang; Christopher P Dillon; Leona L Samson; Douglas R Green
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

Review 2.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

3.  Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.

Authors:  Xiao-Hong Liao; Ye Zhang; Wen-Jie Dong; Zhi-Min Shao; Da-Qiang Li
Journal:  Oncotarget       Date:  2017-06-16

4.  Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice.

Authors:  Yun Rose Li; Kyle D Halliwill; Cassandra J Adams; Vivek Iyer; Laura Riva; Rashid Mamunur; Kuang-Yu Jen; Reyno Del Rosario; Erik Fredlund; Gillian Hirst; Ludmil B Alexandrov; David Adams; Allan Balmain
Journal:  Nat Commun       Date:  2020-01-20       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.